A PILOT STUDY OF A STEROID SULPHATASE INHIBITOR (BN83495) IN PATIENTS WITH RASH DUE TO TREATMENT WITH AN ORAL EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR (EGFR-TKI) FOR NON-SMALL CELL LUNG CANCER (NSCLC)

被引：0
|
作者：
Mileshkin, Linda [1 ]
Mccormack, Chris [1 ]
Michael, Michael [1 ]
Solomon, Ben [1 ]
Urban, Damien [1 ]
Link, Emma [1 ]
Cowan, Linda [1 ]
Zalcberg, John [1 ]
机构：
[1] Peter MacCallum Canc Ctr, Div Canc Med, East Melbourne, Vic, Australia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
rash; EGFR; NSCLC; supportive care;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.24-041
引用
收藏
页码：S1020 / S1020
页数：1
相关论文
共 50 条
  • [1] EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR (EGFR-TKI) RELATED INTERSTITIAL LUNG DISEASE IN TAIWANESE PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Chiang, Chi-Lu
    Tsai, Chun-Ming
    Lee, Yu-Chin
    Chiu, Chao-Hua
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S592 - S592
  • [2] Rare and complex mutations of epidermal growth factor receptor (EGFR) and efficacy of tyrosine kinase inhibitor (TKI) in patients with non-small cell lung cancer (NSCLC).
    Keam, Bhumsuk
    Kim, Dong-Wan
    Park, Jin Hyun
    Lee, Jeong-Ok
    Kim, Tae Min
    Lee, Se-Hoon
    Jeon, Yoon-Kyung
    Chung, Doo Hyun
    Heo, Dae Seog
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] ECONOMIC EVALUATION OF EPIDERMAL GROWTH FACTOR RECEPTOR - TYROSINE KINASE INHIBITOR (EGFR-TKI) DRUGS IN NON-SMALL CELL LUNG CANCER (NSCLC) TREATMENT: A SYSTEMATIC REVIEW OF RECENT STUDIES
    Karim, M.
    Nabil, A. K.
    Khodakarami, N.
    Kum, H. C.
    Foster, M. J.
    Ohsfeldt, R. L.
    VALUE IN HEALTH, 2020, 23 : S46 - S46
  • [4] Smoking history, drug toxicity, and survival in non-small cell lung cancer (NSCLC) patients receiving epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) drugs
    Cooley, M. E.
    Emmons, K. M.
    Li, H.
    Harrington, D. P.
    Christiani, D. C.
    Jackman, D. M.
    Cohen, T.
    Johnson, B. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Clinical Significance of Sequential Treatment with Afatinib in the Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Treatment of Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
    Kobayashi, N.
    Aiko, H.
    Kamimaki, C.
    Mikami, N.
    Kubo, S.
    Tei, Y.
    Hirama, N.
    Katakura, S.
    Teranishi, S.
    Manabe, S.
    Yamamoto, M.
    Kudo, M.
    Kaneko, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [6] SYNERGISTIC EFFECT OF HISTONE DEACETYLASE INHIBITOR IN COMBINATION WITH EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR IN EGFR-TKI RESISTANT NON-SMALL CELL LUNG CANCER CELL LINES
    Han, X.
    Zhang, N.
    Yao, J.
    Shi, Y.
    ANNALS OF ONCOLOGY, 2015, 26
  • [7] Dacomitinib, a second-generation irreversible epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) to treat non-small cell lung cancer
    Nagano, T.
    Tachihara, M.
    Nishimura, Y.
    DRUGS OF TODAY, 2019, 55 (04) : 231 - 236
  • [8] Neoadjuvant and adjuvant epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer
    Zhai, Haoran
    Zhong, Wenzhao
    Yang, Xuening
    Wu, Yi-Long
    TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (01) : 82 - 93
  • [9] Efficacy, Safety And Dosage Of Afatinib In Patients With Non-Small Cell Lung Cancer After Failure Of Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-Tki)
    Park, C.
    Kim, T.
    Shin, H.
    Ban, H.
    Lim, J.
    Kwon, Y.
    Oh, I.
    Kim, Y.
    Lim, S.
    Kim, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [10] Molecular Analysis Identifies A Subset Of Non-small Cell Lung Cancer Patients With Differential Sensitivity To Histone Deacetylase Inhibitor (hdaci)/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (egfr-tki) Treatment
    Jotte, R. M.
    Witta, S. E.
    Spira, A. I.
    Neubauer, M. A.
    Konduri, K.
    Ruxer, R. L.
    Hirsch, F. R.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S559 - S560
12345